Is Praxis Precision Medicines, Inc. profitable?

Praxis Precision Medicines, Inc. is not currently profitable: it reported a net loss of $326.5M over the trailing twelve months, a -3658.5% net margin.

What is Praxis Precision Medicines, Inc.'s earnings per share?

Praxis Precision Medicines, Inc.'s diluted EPS over the trailing twelve months is $-13.38.

Where does Praxis Precision Medicines, Inc.'s income statement data come from?

Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Praxis Precision Medicines, Inc. PRAX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Research and development	$284.3M+6.4%	$267.12M+8.6%	$245.9M+10.8%	$221.98M+19.2%	$186.24M+22.2%
General and administrative	$73.03M+23.6%	$59.08M+8.1%	$54.68M-4.7%	$57.37M+4.5%	$54.89M-2.5%
Other operating expenses	$357.33M+9.5%	$326.2M+8.5%	$300.57M+7.6%	$279.35M+15.9%	$241.13M+15.5%
Total operating expenses	$357.33M+9.5%	$326.2M+8.5%	$300.57M+7.6%	$279.35M+15.9%	$241.13M+15.5%
Operating income	-$357.33M-9.5%	-$326.2M-11.3%	-$293.11M-7.9%	-$271.59M-16.6%	-$233.01M-16.4%
Other income (expense), net	$30.8M+34.3%	$22.93M+14.2%	$20.07M-2.4%	$20.57M+0.6%	$20.45M+17.9%
Net income	-$326.53M-7.7%	-$303.27M-11.1%	-$273.04M-8.8%	-$251.01M-18.1%	-$212.56M-16.3%
Diluted earnings per share	-$13.38+0.7%	-$13.47-3.9%	-$12.96-4.9%	-$12.35-14.6%	-$10.78-4.4%
Basic earnings per share	-$13.38+0.7%	-$13.47-3.9%	-$12.96-4.9%	-$12.35-14.6%	-$10.78-4.4%
Weighted-average shares, diluted	94.8M+9.0%	87M+5.6%	82.4M+3.9%	79.3M+3.5%	76.7M+10.3%
Weighted-average shares, basic	94.8M+9.0%	87M+5.6%	82.4M+3.9%	79.3M+3.5%	76.7M+10.3%
Other income, net (Note 6)	$30.8M+34.3%	$22.93M+14.2%	$20.07M-2.4%	$20.57M+0.6%	$20.45M+17.9%
EBIT	-$357.33M-9.5%	-$326.2M-11.3%	-$293.11M-7.9%	-$271.59M-16.6%	-$233.01M-16.4%
EBITDA	-$357.2M-9.6%	-$326.06M-11.3%	-$292.95M-8.0%	-$271.35M-16.6%	-$232.71M-16.5%
EBITDA	-$357.2M-9.6%	-$326.06M-11.3%	-$292.95M-8.0%	-$271.35M-16.6%	-$232.71M-16.5%
EBIT	-$357.33M-9.5%	-$326.2M-11.3%	-$293.11M-7.9%	-$271.59M-16.6%	-$233.01M-16.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Praxis Precision Medicines, Inc. profitable?: Praxis Precision Medicines, Inc. is not currently profitable: it reported a net loss of $326.5M over the trailing twelve months, a -3658.5% net margin.
What is Praxis Precision Medicines, Inc.'s earnings per share?: Praxis Precision Medicines, Inc.'s diluted EPS over the trailing twelve months is $-13.38.
Where does Praxis Precision Medicines, Inc.'s income statement data come from?: Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.